Additionally, HF can exacerbate obesity due to limitations in physical activity, creating a complex, bidirectional relationship
The license is a reaction to Lilly's Phase 3 lead with Retatrutide: Novo, which did not have an internal triple agonist in the clinic at the time, moved to acquire the fastest-advancing Chinese triple to compete on timeline with Retatrutide
Interestingly, the increased relative abundance of the probiotic Akkermansia may also mediate this effect [76]
There is already an appreciation within the medical literature that a narrow focus within outcomes trials misses the wider benefits of GLP-1 RAs across the CKM spectrum, and there are calls to review the design and analysis of outcomes trials in the CKM space to include more endpoints [44]
The improvement was not overnight, and I am not claiming this is a magic cure
How long do people stay on the medications